Modifying Risk Factors: Strategies That Work Diabetes Mellitus

Louis S. Stryker

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

An estimated 29.1 million Americans are currently diagnosed with diabetes, and this number is expected to increase to 48.3 million Americans by 2050. Correspondingly, the present burden of diabetes among patients undergoing total joint arthroplasty is significant and rising. Diabetes as a chronic condition is a well-established risk factor for complication after total joint arthroplasty. A growing body of evidence also indicates that hyperglycemia in the perioperative period, and not the diagnosis of diabetes alone, is similarly associated with increased complication risk. As a result, a coordinated approach to preoperative screening and optimization, combined with judicious perioperative glycemic control, may present an opportunity to improve outcomes, reduce complications, and avoid complication-related costs for patients undergoing total joint arthroplasty.

Original languageEnglish (US)
JournalJournal of Arthroplasty
DOIs
StateAccepted/In press - Feb 2 2016

Fingerprint

Arthroplasty
Diabetes Mellitus
Joints
Perioperative Period
Hyperglycemia
Costs and Cost Analysis

Keywords

  • Diabetes
  • Hyperglycemia
  • Preoperative optimization
  • Risk factors
  • Total joint athroplasty

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Modifying Risk Factors : Strategies That Work Diabetes Mellitus. / Stryker, Louis S.

In: Journal of Arthroplasty, 02.02.2016.

Research output: Contribution to journalArticle

@article{a53eda2d92b74cbaa220f571d0540a0d,
title = "Modifying Risk Factors: Strategies That Work Diabetes Mellitus",
abstract = "An estimated 29.1 million Americans are currently diagnosed with diabetes, and this number is expected to increase to 48.3 million Americans by 2050. Correspondingly, the present burden of diabetes among patients undergoing total joint arthroplasty is significant and rising. Diabetes as a chronic condition is a well-established risk factor for complication after total joint arthroplasty. A growing body of evidence also indicates that hyperglycemia in the perioperative period, and not the diagnosis of diabetes alone, is similarly associated with increased complication risk. As a result, a coordinated approach to preoperative screening and optimization, combined with judicious perioperative glycemic control, may present an opportunity to improve outcomes, reduce complications, and avoid complication-related costs for patients undergoing total joint arthroplasty.",
keywords = "Diabetes, Hyperglycemia, Preoperative optimization, Risk factors, Total joint athroplasty",
author = "Stryker, {Louis S.}",
year = "2016",
month = "2",
day = "2",
doi = "10.1016/j.arth.2016.02.084",
language = "English (US)",
journal = "Journal of Arthroplasty",
issn = "0883-5403",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Modifying Risk Factors

T2 - Strategies That Work Diabetes Mellitus

AU - Stryker, Louis S.

PY - 2016/2/2

Y1 - 2016/2/2

N2 - An estimated 29.1 million Americans are currently diagnosed with diabetes, and this number is expected to increase to 48.3 million Americans by 2050. Correspondingly, the present burden of diabetes among patients undergoing total joint arthroplasty is significant and rising. Diabetes as a chronic condition is a well-established risk factor for complication after total joint arthroplasty. A growing body of evidence also indicates that hyperglycemia in the perioperative period, and not the diagnosis of diabetes alone, is similarly associated with increased complication risk. As a result, a coordinated approach to preoperative screening and optimization, combined with judicious perioperative glycemic control, may present an opportunity to improve outcomes, reduce complications, and avoid complication-related costs for patients undergoing total joint arthroplasty.

AB - An estimated 29.1 million Americans are currently diagnosed with diabetes, and this number is expected to increase to 48.3 million Americans by 2050. Correspondingly, the present burden of diabetes among patients undergoing total joint arthroplasty is significant and rising. Diabetes as a chronic condition is a well-established risk factor for complication after total joint arthroplasty. A growing body of evidence also indicates that hyperglycemia in the perioperative period, and not the diagnosis of diabetes alone, is similarly associated with increased complication risk. As a result, a coordinated approach to preoperative screening and optimization, combined with judicious perioperative glycemic control, may present an opportunity to improve outcomes, reduce complications, and avoid complication-related costs for patients undergoing total joint arthroplasty.

KW - Diabetes

KW - Hyperglycemia

KW - Preoperative optimization

KW - Risk factors

KW - Total joint athroplasty

UR - http://www.scopus.com/inward/record.url?scp=84964289621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964289621&partnerID=8YFLogxK

U2 - 10.1016/j.arth.2016.02.084

DO - 10.1016/j.arth.2016.02.084

M3 - Article

AN - SCOPUS:84964289621

JO - Journal of Arthroplasty

JF - Journal of Arthroplasty

SN - 0883-5403

ER -